Melatonin Modulation of the Chronic Dexamethasone-induced Adrenal Insufficiency

Overview

Journal Endocrine

Date 2025 Jan 29

PMID 39881044

Authors

Banalata Mohanty

Brijesh Kumar Mishra

Affiliations

Soon will be listed here.

Abstract

Purpose: Chronic exposure to synthetic glucocorticoids/GCs, widely in use to treat many diseases, may compromise the hypothalamic-pituitary-adrenal/HPA axis leading to a condition of adrenal insufficiency/AI. This study demonstrates the efficacy of the melatonin/MEL in amelioration of chronic dexamethasone (DEX)-induced AI.

Methods: Mice (Parkes Strain/Male/8 weeks old/30-33 g) were maintained in four groups (10 mice/group) for 30 days: Group 1/Control received intraperitoneal (i.p) vehicle (alcoholic 0.9% normal saline); Group II/DEX (400 µg/kg BW/day/i.p), Group III/(DEX + MEL 750 µg/kg BW/day/subcutaneous), and Group IV received only MEL. Adrenal, pituitary, and blood samples were collected from six mice/groups. Four mice/groups were subjected to the Lipopolysaccharide (LPS) challenge. Adrenal histology, ACTH immunohistochemistry, and plasma ACTH and corticosterone/CORT levels were measured.

Results: DEX exposure suppressed the pituitary ACTH expression significantly from control as revealed by morphometry and circulating hormones (Density, p < 0.01; size, immunointensity, plasma ACTH, and CORT; p < 0.001). Increased adrenal histopathology indicated probable AI. MEL co-supplementation significantly increased the corticotropes' density (p < 0.05), size (p < 0.001), immunointensity (<0.01), and plasma level of ACTH (p < 0.01) compared to the DEX group. The adreno-cortical width, zona fasciculata cell density and size, and the plasma CORT level (p < 0.001) were also significantly increased. The enhanced CORT response of the HPA axis in the DEX + MEL group compared to the DEX group on the LPS challenge provides support for the MEL restoration of the HPA axis functioning.

Conclusion: Further research on the MEL modulation of the HPA axis may support its role in preventing AI.

References

Martinac M, Pehar D, Karlovic D, Babic D, Marcinko D, Jakovljevic M . Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder. Acta Clin Croat. 2014; 53(1):55-71. View

Walker D, Spencer K . Glucocorticoid programming of neuroimmune function. Gen Comp Endocrinol. 2017; 256:80-88. DOI: 10.1016/j.ygcen.2017.07.016. View

Paragliola R, Papi G, Pontecorvi A, Maria Corsello S . Treatment with Synthetic Glucocorticoids and the Hypothalamus-Pituitary-Adrenal Axis. Int J Mol Sci. 2017; 18(10). PMC: 5666882. DOI: 10.3390/ijms18102201. View

Pipitone N, Salvarani C . Treatment of inflammatory myopathies. Expert Rev Clin Immunol. 2018; 14(7):607-621. DOI: 10.1080/1744666X.2018.1491307. View

Kadmiel M, Cidlowski J . Glucocorticoid receptor signaling in health and disease. Trends Pharmacol Sci. 2013; 34(9):518-30. PMC: 3951203. DOI: 10.1016/j.tips.2013.07.003. View

Broersen L, Pereira A, Jorgensen J, Dekkers O . Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2015; 100(6):2171-80. DOI: 10.1210/jc.2015-1218. View

Borresen S, Klose M, Glintborg D, Watt T, Andersen M, Feldt-Rasmussen U . Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency. J Clin Endocrinol Metab. 2022; 107(7):2065-2076. DOI: 10.1210/clinem/dgac151. View

Pofi R, Feliciano C, Sbardella E, Argese N, Woods C, Grossman A . The Short Synacthen (Corticotropin) Test Can Be Used to Predict Recovery of Hypothalamo-Pituitary-Adrenal Axis Function. J Clin Endocrinol Metab. 2018; 103(8):3050-3059. DOI: 10.1210/jc.2018-00529. View

Cipolla-Neto J, do Amaral F . Melatonin as a Hormone: New Physiological and Clinical Insights. Endocr Rev. 2018; 39(6):990-1028. DOI: 10.1210/er.2018-00084. View

10.

Falcon J, Besseau L, Fuentes M, Sauzet S, Magnanou E, Boeuf G . Structural and functional evolution of the pineal melatonin system in vertebrates. Ann N Y Acad Sci. 2009; 1163:101-11. DOI: 10.1111/j.1749-6632.2009.04435.x. View

11.

Reiter R, Tan D, Galano A . Melatonin reduces lipid peroxidation and membrane viscosity. Front Physiol. 2014; 5:377. PMC: 4186275. DOI: 10.3389/fphys.2014.00377. View

12.

Reiter R, Mayo J, Tan D, Sainz R, Alatorre-Jimenez M, Qin L . Melatonin as an antioxidant: under promises but over delivers. J Pineal Res. 2016; 61(3):253-78. DOI: 10.1111/jpi.12360. View

13.

Konakchieva R, Mitev Y, Almeida O, Patchev V . Chronic melatonin treatment and the hypothalamo-pituitary-adrenal axis in the rat: attenuation of the secretory response to stress and effects on hypothalamic neuropeptide content and release. Biol Cell. 1998; 89(9):587-96. View

14.

Konakchieva R, Mitev Y, Almeida O, Patchev V . Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology. 1998; 67(3):171-80. DOI: 10.1159/000054312. View

15.

Torres-Farfan C, Valenzuela F, Ebensperger R, Mendez N, Campino C, Richter H . Circadian cortisol secretion and circadian adrenal responses to ACTH are maintained in dexamethasone suppressed capuchin monkeys (Cebus apella). Am J Primatol. 2007; 70(1):93-100. DOI: 10.1002/ajp.20461. View

16.

Wu Y, Zhou J, Balesar R, Unmehopa U, Bao A, Jockers R . Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone. J Comp Neurol. 2006; 499(6):897-910. DOI: 10.1002/cne.21152. View

17.

Mokhtar D, Hussein M, Hassan A . Melatonin Elicits Stimulatory Action on the Adrenal Gland of Soay Ram: Morphometrical, Immunohistochemical, and Ultrastructural Study. Microsc Microanal. 2017; 23(6):1173-1188. DOI: 10.1017/S1431927617012727. View

18.

Hussein M, Mokhtar D, Hassan A . Melatonin activates the vascular elements, telocytes, and neuroimmune communication in the adrenal gland of Soay rams during the non-breeding season. Protoplasma. 2019; 257(2):353-369. DOI: 10.1007/s00709-019-01441-8. View

19.

Tongjaroenbuangam W, Ruksee N, Mahanam T, Govitrapong P . Melatonin attenuates dexamethasone-induced spatial memory impairment and dexamethasone-induced reduction of synaptic protein expressions in the mouse brain. Neurochem Int. 2013; 63(5):482-91. DOI: 10.1016/j.neuint.2013.08.011. View

20.

Beishuizen A, Thijs L . Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis. J Endotoxin Res. 2003; 9(1):3-24. DOI: 10.1179/096805103125001298. View